ANP32A (Acidic Nuclear Phosphoprotein 32 Family Member A) is a multifunctional protein involved in diverse cellular processes, including chromatin remodeling, apoptosis, and regulation of protein phosphatase activity. It belongs to the ANP32 family, characterized by an N-terminal leucine-rich repeat (LRR) domain and a C-terminal acidic tail. ANP32A has gained attention due to its role in viral replication, particularly in supporting the polymerase activity of influenza A virus by interacting with viral RNA polymerase subunits. Dysregulation of ANP32A has also been implicated in cancer progression, neurodegenerative diseases, and developmental disorders.
Antibodies targeting ANP32A are essential tools for studying its expression, localization, and molecular interactions. They enable researchers to investigate its tissue-specific distribution, quantify expression changes under pathological conditions (e.g., tumorigenesis or viral infection), and explore its functional mechanisms in cellular pathways. Polyclonal and monoclonal ANP32A antibodies are widely used in techniques like Western blotting, immunohistochemistry, and immunofluorescence. Recent studies highlight its potential as a therapeutic target, particularly in antiviral strategies and cancer treatment. However, challenges remain in understanding isoform-specific functions, post-translational modifications, and context-dependent roles across different diseases. Validated ANP32A antibodies are critical for advancing research into its dual roles in cellular homeostasis and disease pathogenesis.